Florida Institute and MPWRM Resource Center Fund Amend Surgical (PR Newswire)

Florida Institute and MPWRM Resource Center Fund Amend Surgical

UF Innovate | Sid Martin Biotech alum Amend Surgical, Inc., an Alachua-based medical device company, announced that it has finalized a funding agreement with the Institute for Commercialization of Florida Technology (the Florida Institute) along with being awarded a substantial product development funding from The Michigan-Pittsburgh-Wyss Regenerative Medicine (MPWRM) Resource Center.

The capital investments, along with the technical collaborations from these four universities, will allow Amend Surgical to accelerate the development and market launch of Amend Tissue Tape™, a biocompatible, hydrogel-based adhesive that safely adheres in wet environments such as the oral cavity. Tissue Tape is an easy to apply, clear, smooth strip that forms a protective barrier between the wound and surrounding tissues. The device stays in place during wound healing to prevent further irritation, contamination and provides improvement in wound healing and patient comfort following dental surgery or soft tissue injuries. Amend Surgical is actively developing both non-resorbable and resorbable product options for applications in periodontal and oral surgical procedures. The intellectual property for the Tissue Tape™ technology was licensed from The Wyss Institute at Harvard University in June 2020. 

The Florida Institute supports new company development and expansion based on publicly funded research and bridges early funding gaps for early-stage Florida-based technology companies. This new funding agreement represents Florida Institutes second investment in the team at Amend Surgical. The MPWRM Resource Center was established as an interdisciplinary partnership amongst the University of Michigan, the University of Pittsburgh, and the Wyss Institute, along with technology, clinical, regulatory, marketing, and commercial translation experts from private practice and industry. Through this collaborative effort, their goal is to accelerate clinical adoption of promising technologies by providing the interdisciplinary expertise and resources to guide technologies towards FDA submissions.

Learn more about Florida Institute and MPWRM Resource Center Fund Amend Surgical